Sustainability reports and resources archive
Home / Sustainability / Sustainability reports and resources / Archive
Find our historic sustainability reports and resources, dating from 2015 – 2019
2019
2018
2017
This is our third sustainability report, and it describes our progress and challenges in 2017. The content of this report is based on those sustainability issues deemed material through formal stakeholder engagement and analysis.
This summary is meant to provide employees with the essential information on our sustainability strategy and initiatives in 2017.
Here you can see metrics for each of AstraZeneca's sustainability priorities - Access to Healthcare, Environmental Protection, Ethics & Transparency and Foundations - from 2015, 2016, and 2017.
Bureau Veritas independently verified sustainability information of the 2017 Annual Report.
This graphic shows the impacts HHA has had on people’s lives in numbers, in terms of trained healthcare workers, healthcare facilities activated, etc.
Bureau Veritas independently verified the target statuses of the 2017 Sustainability Report.
This graphic shows issues that are material for AstraZenenca and its diverse stakeholders. Each issue is categorized into one of our 4 priority areas - Access to Healthcare, Environmental Protection, Ethics & Transparency, and Foundations.
This graphic shows how AstraZeneca is responding to non-communicable diseases (NCDs) across various countries.
This graphic shows how each region across the world is participating in employee Global Health & Well-Being Programmes. These programmes include four essential health activities - Physical activity, Healthy drinking & eating, Stress/pressure management, and Tobacco cessation.
This graphic gives details on hypertension (high blood pressure), its effects on patients and the economy, and its prevalence in Africa.
This graphic explains how we are working to reduce GHG emissions, across the three main parts of our value chain - Upstream, Operations, and Downstream.
This graphic explains how our pre-clinical animal studies tests are run, through a process called the 3Rs (Replacement, Refinement, and Reduction).
This graphic details our efforts to drive and foster a responsible supply chain. We do this through quality audits, environmental assessments, and third-party risk management assessments.
This document outlines the history of HHA, its milestones in providing access to healthcare, and importance in a region burdened by hypertension (high blood pressure).